Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles

Kunda, NK and Alfagih, IM and Hutcheon, GA and Saleem, IY and Miyaji, EN and Figueiredo, DB and Gonçalves, VM and Ferreira, DM and Dennison, SR and Somavarapu, S (2015) Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles. International Journal of Pharmaceutics, 495 (2). pp. 903-912. ISSN 0378-5173

[img] Text
Pulmonary Dry Powder Vaccine of Pneumococcal Antigen Loaded Nanoparticles.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (898kB)

Abstract

Pneumonia, caused by Streptococcus pneumoniae, mainly affects the immunocompromised, the very young and the old, and remains one of the leading causes of death. A steady rise in disease numbers from non-vaccine serotypes necessitates a new vaccine formulation that ideally has better antigen stability and integrity, does not require cold-chain and can be delivered non-invasively. In this study, a dry powder vaccine containing an important antigen of S. pneumoniae, pneumococcal surface protein A (PspA) that has shown cross-reactivity amongst serotypes to be delivered via the pulmonary route has been formulated. The formulation contains the antigen PspA adsorbed onto the surface of polymeric nanoparticles encapsulated in l-leucine microparticles that can be loaded into capsules and delivered via an inhaler. We have successfully synthesized particles of ∼150 nm and achieved ∼20 μg of PspA adsorption per mg of NPs. In addition, the spray-dried powders displayed a FPF of 74.31 ± 1.32% and MMAD of 1.70 ± 0.03 μm suggesting a broncho-alveolar lung deposition facilitating the uptake of the nanoparticles by dendritic cells. Also, the PspA released from the dry powders maintained antigen stability (SDS-PAGE), integrity (Circular dichroism) and activity (lactoferrin binding assay). Moreover, the released antigen also maintained its antigenicity as determined by ELISA.

Item Type: Article
Uncontrolled Keywords: 1115 Pharmacology And Pharmaceutical Sciences
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Elsevier
Date Deposited: 28 Oct 2015 09:18
Last Modified: 07 Sep 2017 10:00
DOI or Identification number: 10.1016/j.ijpharm.2015.09.034
URI: http://researchonline.ljmu.ac.uk/id/eprint/2256

Actions (login required)

View Item View Item